Sucralfate pp 271-276 | Cite as

Therapy of Esophagitis

  • Orlando Roy Charles 


Reflux esophagitis is a chronic disorder characterized by the symptoms of heartburn and regurgitation. Heartburn is extremely common in the United States, reportedly experi- enced by approximately 1/3 of the population on a monthly basis and by approximately 1/12 of the population on a daily basis. In addition to heartburn and other symptoms, reflux esophagitis has importance because it results in injury to the esophageal tissues ranging from inflammation to ulceration and healing of these lesions occasionally produces such undesirable complications as stricture formation and the development of the premalignant columnar-lined (Barrett’s) esophagus.


Reflux Disease Reflux Esophagitis Lower Esophageal Sphincter Pressure Esophageal Epithelium Prolonged Contact 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bremmer CG, Marks S, Segal I, et al. Reflux esophagitis therapy: Sucralfate versus ranitidine in a double blinded multicentre trial Am J Med 91(suppl 2A):119–122, 1991.CrossRefGoogle Scholar
  2. 2.
    Jorgensen F, Eisborg L: Sucralfate versus cimetidine in the treatment of reflux esophagitis with special reference to the esophageal motor function. Am J Med 91(suppl 2A):114–118, 1991.CrossRefGoogle Scholar
  3. 3.
    Ros E, Toledo V, Bordas JM, et al: Healing of erosive esophagitis with sucralfate and cimetidine: Influence of pretreatment on lower esophageal sphincter pressure and serum pepsinogen I levels. Am J Med 91(suppl 2A):107–113, 1991.CrossRefGoogle Scholar
  4. 4.
    Simon B, Mueller P: Comparison of the effect of sucralfate and ranitidine in reflux esophagitis. Am J Med 83(suppl 3B):43–47, 1987.PubMedCrossRefGoogle Scholar
  5. 5.
    Hameeteman W, Boomgaard DM vd, Dekker W, et al: Sucralfate versus cimetidine in reflux esophagitis. A single blind multicenter study. J Clin Gastroenterol 9:390–384, 1987. These first five articles compare the efficacy of sucralfate to that of an H2RA.PubMedCrossRefGoogle Scholar
  6. 6.
    Evreux M: Sucralfate versus alginate/antacid in the treatment of peptic esophagitis. Am J Med 83(suppl 3B):48–50, 1987.PubMedCrossRefGoogle Scholar
  7. 7.
    Laitinen S, Stahlberg M, Kairaluoma MI, et al: Sucralfate and alginate/antacid in reflux esophagitis. Scand J Gastroenterol 20:229–232, 1985. These two articles compare the efficacy of sucralfate to Gaviscon.PubMedCrossRefGoogle Scholar
  8. 8.
    Pace F, Lazzaroni M, Bianci Porro G: Failure of sucralfate in the treatment of refractory esophagitis versus high dose famotidine. An endoscopic study. Scand J Gastroenterol 26:491–494, 1991. This article demonstrates the inability of sucralfate to heal lesions in patients refractory to an H2RA.PubMedCrossRefGoogle Scholar
  9. 9.
    Schotborgh RH, Hameeteman W, Dekker W, et al: Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis. Am J Med 86(suppl 6A):77–80, 1989. This article indicates that the combination of sucralfate with an H2RA offers minimal advantages over sucralfate alone and that sucralfate in low dose is unable to prevent relapse of reflux esophagitis.PubMedCrossRefGoogle Scholar
  10. 10.
    Weiss W, Brunner H, Buttner GR, et al: Therapie der refluxosophagitis mit sucralfat. Dtsch Med Wochenschr 108:1706–1711, 1983.PubMedCrossRefGoogle Scholar
  11. 11.
    Williams RM, Orlando RC, Bozymski EM, et al: Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis. Am J Med 83:61–66, 1987.PubMedCrossRefGoogle Scholar
  12. 12.
    Carling L, Cronstedt J, Engqvist A, et al: Sucralfate versus placebo in reflux esophagitis: A double-blind multicenter study. Scand J Gastroenterol 23:1117–1124, 1988. These three articles compare sucralfate to placebo in the treatment of reflux disease.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press 1995

Authors and Affiliations

  • Orlando Roy Charles 
    • 1
  1. 1.Tulane University School of MedicineNew Orleans

Personalised recommendations